The key factors that are driving the growth of the market are the rising number of surgeries and chronic diseases, and the growing rate of blood donation and blood tests. However, risks associated with blood transfusion hamper the market growth.
According to statistics by the WHO, Denmark recorded the highest blood donation rate while the average number of donations across Europe ranges from 6 to 67.6 per 1,000 residents. With the surge in blood disorders, the need for blood is also increasing. For instance, as per data revealed by the European Hematology Association, ~80 million people in the European Union (EU) are currently affected by blood disorders. Also, according to Global Blood Therapeutics, sickle cell disease (SCD), which is a rare, inherited disorder, affected more than 52,000 people in Europe in 2020. Patients suffering from this condition may require blood transfusions throughout their lives. Similarly, according to the WHO, Europe has ~25% of the world’s total number of cancer cases, with ~3.7 million new patients every year. Many of them need blood transfusions, sometimes daily, during their chemotherapy treatment. Blood donors in Italy are often recruited by offering rewards or incentives for donating blood, which may include t-shirts, event tickets, or opportunity drawings for televisions and expensive cars. For instance, in 2021, the WHO designated Italy as the host of World Blood Donor Day, with the Istituto Superiore di Sanità (ISS) leading the activities for the global event.
The European vacuum blood collection tube market is severely affected due to the surge in COVID-19 cases in the region. As per the European Centre for Disease Prevention and Control (ECDC), lockdowns were reintroduced in the UK, Spain, Italy, and Ireland in 2021, in response to the emergence of the second wave of infection. Moreover, governments of many countries are increasing their testing capacities. Countries such as Italy, Spain, and France have recorded the most significant number of positive cases and deaths. The exponential spread of COVID-19 has exerted excess stress on the region's healthcare system, raising the demand for diagnostic tests, such as blood tests or antigen tests. Much healthcare research institutes and pharmaceutical companies are stepping forward to discover a therapeutic solution for COVID-19. Companies are now focused on the development of the antibody-specific COVID-19 blood test. The rising number of blood tests performed for COVID-19 diagnosis is likely to boost the demand for the vacuum blood collection tube market in the region.
The Europe Vacuum Blood Collection Tube Market is valued at US$ 761.44 Million in 2021, it is projected to reach US$ 1,295.51 Million by 2028.
As per our report Europe Vacuum Blood Collection Tube Market, the market size is valued at US$ 761.44 Million in 2021, projecting it to reach US$ 1,295.51 Million by 2028. This translates to a CAGR of approximately 7.9% during the forecast period.
The Europe Vacuum Blood Collection Tube Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Vacuum Blood Collection Tube Market report:
The Europe Vacuum Blood Collection Tube Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Vacuum Blood Collection Tube Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Vacuum Blood Collection Tube Market value chain can benefit from the information contained in a comprehensive market report.